Taking aim at the target of true potential.
One of the benefits of having such deep and broad experience represented on our leadership team is that we have more opportunities to have the right conversations with the right people about the availability of potential assets. These conversations aren’t characterized by
“We have money. What are you selling?” Instead, they focus on taking careful and thoughtful aim at determining whether acquiring a particular product would be the right fit for them and for us.
At New American Therapeutics, Inc., we focus on general specialty pharma and have a progressive commercialization approach that concentrates on:
- Identifying specific unmet needs in the marketplace and targeting products that provide solutions.
- Developing and implementing customized tactics that provide value to healthcare providers through information and support.
- Creating a field force that has a laser-like focus on providing healthcare providers the information they can use to make better decisions about therapeutics, that is fully committed to growing a specific brand and that is flexible enough to react swiftly to changing marketplace dynamics.
- Repositioning the traditional relationship between pharmaceutical company representatives and healthcare provider offices from one that can seem intrusive at times to one that’s focused on serving mutual needs more effectively.
- Taking products to market quickly and profitably, while growing them through a combination of strategic marketing and lifecycle management efforts.